Evidence map›Paper›PMID 23226087›Full record

ArticleBreeding science2012

Construction of a high-density reference linkage map of tea (Camellia sinensis).

Fumiya Taniguchi, Kazumi Furukawa, Sakura Ota-Metoku, Nobuo Yamaguchi, Tomomi Ujihara, Izumi Kono, Hiroyuki Fukuoka, Junichi Tanaka

Abstract read
In one paragraph

Article in Breeding science, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Genome Survey and SSR Analysis ofGenetics research · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. TeaMiD: a comprehensive database of simple sequence repeat markers of tea.Database : the journal of biological databases and curation · 2020
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fumiya TaniguchiMakurazaki Tea Research Station, NARO Institute of Vegetable and Tea Science , 87 Seto, Makurazaki, Kagoshima 898-0032, Japan ; Graduate School of Life and Environmental Science, University of Tsukuba , 2-1-18 Kannondai, Tsukuba, Ibaraki 305-8518, Japan.
Kazumi Furukawa
Sakura Ota-Metoku
Nobuo Yamaguchi
Tomomi Ujihara
Izumi Kono
Hiroyuki Fukuoka
Junichi Tanaka

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A few linkage maps of tea have been constructed using pseudo-testcross theory based on dominant marker systems. However, dominant markers are not suitable as landmark markers across a wide range of materials. Therefore, we developed co-dominant SSR markers from genomic DNA and ESTs and constructed a reference map using these co-dominant markers as landmarks. A population of 54 F(1) clones derived from reciprocal crosses between 'Sayamakaori' and 'Kana-Ck17' was used for the linkage analysis. Maps of both parents were constructed from the F(1) population that was taken for BC(1) population. The order of most of the dominant markers in the parental maps was consistent. We constructed a core map by merging the linkage data for markers that detected polymorphisms in both parents. The core map contains 15 linkage groups, which corresponds to the basic chromosome number of tea. The total length of the core map is 1218 cM. Here, we present the reference map as a central core map sandwiched between the parental maps for each linkage group; the combined maps contain 441 SSRs, 7 CAPS, 2 STS and 674 RAPDs. This newly constructed linkage map can be used as a basic reference linkage map of tea.

Indexed as

Camellia sinensislinkage mapRAPDreference mapSSRSTStea

Identifiers

PMID23226087
PMCPMC3501944

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.